Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
Payne AB, Ray LC, Cole MM, Canning M, Houck K, Shah HJ, Farrar JL, Lewis NM, Fothergill A, White EB, Feldstein LR, Roper LE, Lee F, Kriss JL, Sims E, Spicknall IH, Nakazawa Y, Gundlapalli AV, Shimabukuro T, Cohen AL, Honein MA, Mermin J, Payne DC. Payne AB, et al. Among authors: feldstein lr. MMWR Morb Mortal Wkly Rep. 2022 Dec 9;71(49):1560-1564. doi: 10.15585/mmwr.mm7149a5. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36480479 Free PMC article.
Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults - United States, August 2022-July 2023.
Chard AN, Dalton AF, Diallo AO, Moulia DL, Deputy NP, Zecca IB, Quilter LAS, Kachur RE, McCollum AM, Rowlands JV, Britton AN, Fisher R, Chai SJ, Licherdell E, Still WL, Morris AL, Castilho JL, Markus TM, Morrow AS, Danza P, Hansen AP, Ali SI, Wegner CW, Weber R, Betancourt GS, Zipprich J, Sutton M, Pathela P, Hawkins S, Wendel KA, Feldstein LR. Chard AN, et al. Among authors: feldstein lr. MMWR Morb Mortal Wkly Rep. 2024 Oct 10;73(40):896-902. doi: 10.15585/mmwr.mm7340a2. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39388387 Free PMC article.
Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States.
Feldstein LR, Ruffin J, Wiegand RE, Borkowf CB, James-Gist J, Babu TM, Briggs-Hagen M, Chappell J, Chu HY, Englund JA, Kuntz JL, Lauring AS, Lo N, Carone M, Lockwood C, Martin ET, Midgley CM, Monto AS, Naleway AL, Ogilvie T, Saydah S, Schmidt MA, Schmitz JE, Smith N, Sohn I, Starita L, Talbot HK, Weil AA, Grijalva CG. Feldstein LR, et al. J Infect Dis. 2025 Jan 8:jiaf007. doi: 10.1093/infdis/jiaf007. Online ahead of print. J Infect Dis. 2025. PMID: 39774936
A framework for monitoring RSV prevention product effectiveness in the United States.
Roper LE, Link-Gelles R, Surie D, DeCuir J, Zambrano LD, Prill MM, Havers FP, Jones JM, Melgar M, Hall AJ, Whitehead RD Jr, McMorrow ML, Ioannou GN, Hernandez-Romieu AC, Britton A, Novosad S, Martin A, Feldstein LR, Bajema KL, Kirking H, Moline H, Campbell AP, Aslan M, Hatfield K, Dawood F, Slayton R, Reddy S, Gomes D, Fleming-Dutra KE, Payne AB. Roper LE, et al. Among authors: feldstein lr. Vaccine. 2025 Jan 2;45:126633. doi: 10.1016/j.vaccine.2024.126633. Online ahead of print. Vaccine. 2025. PMID: 39755055
Protection from COVID-19 vaccination and prior SARS-CoV-2 infection among children aged 6 months - 4 years, United States, September 2022-April 2023.
Feldstein LR, Ruffin J, Wiegand R, Grant L, Babu TM, Briggs-Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Kuntz J, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Naleway AL, Newes-Adeyi G, Odame-Bamfo L, Olsho LE, Phillips AL, Rai RP, Saydah S, Smith N, Tyner H, Vaughan M, Weil AA, Yoon SK, Britton A, Gaglani M. Feldstein LR, et al. J Pediatric Infect Dis Soc. 2024 Dec 5:piae121. doi: 10.1093/jpids/piae121. Online ahead of print. J Pediatric Infect Dis Soc. 2024. PMID: 39656907
Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa.
Chiwandire N, Walaza S, von Gottberg A, Wolter N, Du Plessis M, Moosa F, Groome MJ, Nel J, Variava E, Dawood H, Makhasi M, Feldstein LR, Marcenac P, Lafond KE, Samuels AM, Cohen C. Chiwandire N, et al. Among authors: feldstein lr. Int J Epidemiol. 2024 Aug 14;53(5):dyae116. doi: 10.1093/ije/dyae116. Int J Epidemiol. 2024. PMID: 39305220 Free PMC article.
Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage.
Lewnard JA, Mahale P, Malden D, Hong V, Ackerson BK, Lewin BJ, Link-Gelles R, Feldstein LR, Lipsitch M, Tartof SY. Lewnard JA, et al. Among authors: feldstein lr. medRxiv [Preprint]. 2024 Apr 19:2024.04.17.24305964. doi: 10.1101/2024.04.17.24305964. medRxiv. 2024. Update in: Nat Commun. 2024 Oct 3;15(1):8550. doi: 10.1038/s41467-024-52668-w PMID: 38699313 Free PMC article. Updated. Preprint.
Long-Term Symptoms Associated With SARS-CoV-2 Infection Among Blood Donors.
Shah MM, Spencer BR, James-Gist J, Haynes JM, Feldstein LR, Stramer SL, Jones JM, Saydah SH. Shah MM, et al. Among authors: feldstein lr. JAMA Netw Open. 2024 Apr 1;7(4):e245611. doi: 10.1001/jamanetworkopen.2024.5611. JAMA Netw Open. 2024. PMID: 38587842 Free PMC article.
85 results